$3.00
-0.16-5.06%
Last update: Oct 30, 7:48 PM
Pulmonx Corp
LUNGNASDAQ
Pulmonx (LUNG) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pulmonx (LUNG) last issued guidance on October 27, 2026 for fiscal year 2026. The company guided revenue in the range of $90M - $92M for the period.
Compared to prior guidance, Pulmonx maintained its revenue forecast from a prior range of $90M - $92M.
Pulmonx has issued 19 guidance updates between November 3, 2022 and October 27, 2026. During this period, the company raised its outlook 6 times and lowered it 4 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.26 | $-0.28 | $-0.33 | $-0.39 |
| Actual | $-0.19 | $-0.24 | $-0.33 | $-0.25 |
| Surprise | +26.9% | +14.3% | 0.00% | +35.9% |
| Revenue | ||||
| Estimate | $22.0M | $22.4M | $20.4M | $21.7M |
| Actual | $22.8M | $22.8M | $20.6M | $22.6M |
| Surprise | +4.00% | +1.76% | +1.10% | +3.98% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.23 | $-0.25 | $-0.23 | $-0.20 |
| Revenue | ||||
| Consensus | $25.0M | $22.6M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $-0.19 | $-0.26 | 26.9 % |
| Q2 | Jul 29, 2026 | $-0.24 | $-0.28 | 14.3 % |
| Q1 | Apr 29, 2026 | $-0.33 | $-0.33 | 0.00 % |
| Q4 | Mar 4, 2026 | $-0.25 | $-0.39 | 35.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $22.84M | $21.96M | 4.00 % |
| Q2 | Jul 29, 2026 | $22.76M | $22.36M | 1.76 % |
| Q1 | Apr 29, 2026 | $20.59M | $20.36M | 1.10 % |
| Q4 | Mar 4, 2026 | $22.60M | $21.73M | 3.98 % |
